MENU
RZLT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rezolute (RZLT) Ownership - Who owns Rezolute?
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases... Show more
Profile
Industry
N/A
Address
275 Shoreline Drive
Phone
+1 650 206-4507
Employees
51
Web
https://www.rezolutebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
763.86M
P/E Ratio
N/A
Total Cash
86.89M
Projected Growth
N/A
Total Debt
1.78M
Revenue
N/A
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash/Share
0.96
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RZLT
Capitalization
764M
P/E Ratio
N/A
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash
86.9M
Total Cash/Share
0.96
Total Debt
1.78M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
82.6M
P/B Ratio
4.71
Cash Flow
N/A
Earnings
-1.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
61K
Current Ratio
8.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-77.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-80.01
Shares Held By Institutions
619M
Shares Outstanding - Current
90.8M
Total Liabilities
12.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
71.837
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RZLT showed earnings on September 17, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
275 Shoreline Drive
Phone
+1 650 206-4507
Employees
51
Web
https://www.rezolutebio.com